medivant tirzepatide FDA Grants a New Indication for Obesity Management Tirzepatide Protocol Training as Medical
Description
One interesting observation in this report is the onset of hyposalivation in which it was noted 4 weeks after starting semaglutide
Wigginton, you brought up Medicare
It fundamentally changes what this class of drugs can achieve
Stopping will likely result in regain, as we saw in trials
In December 2025, the Food and Drug Administration (FDA) approved Mounjaro (tirzepatide) for children ages 10 years and older for the treatment of type 2 diabetes
